Abound Wealth Management Glaukos Corp Transaction History
Abound Wealth Management
- $271 Billion
- Q2 2024
A detailed history of Abound Wealth Management transactions in Glaukos Corp stock. As of the latest transaction made, Abound Wealth Management holds 6 shares of GKOS stock, worth $733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6
Previous 6
-0.0%
Holding current value
$733
Previous $566,000
25.62%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
303Shares Held
47MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$983 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$667 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$232 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$227 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$197 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.82B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...